Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma.
liver cancer
liver resection
radiofrequency based device
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
19 Mar 2019
19 Mar 2019
Historique:
received:
18
02
2019
revised:
12
03
2019
accepted:
14
03
2019
entrez:
22
3
2019
pubmed:
22
3
2019
medline:
22
3
2019
Statut:
epublish
Résumé
Hepatocellular carcinoma (HCC) often develops on a background of chronic inflammation and a complex immunosuppressive network with increased regulatory T cells, impaired CD8⁺ T cells and the secretion of immunosuppressive cytokines. Previous clinical studies have reported a superior disease-free survival (DFS) following a radiofrequency-based ablation or resection in HCC tumours compared to conventional liver resection techniques. The aim of this study was to investigate whether there is any correlation with the use of a radiofrequency-assisted liver resection and clinical outcome. Patients' peripheral blood was collected prior and 7 days following surgery from patients undergoing a liver resection for HCC. There were 5 liver resections performed using CUSA and 6 liver resections with the RF-based device, Habib Patients undergoing an RF-assisted liver resection with Habib A liver resection with RF-based device Habib
Identifiants
pubmed: 30893948
pii: jcm8030385
doi: 10.3390/jcm8030385
pmc: PMC6463076
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
Nagy Habib is an inventor of the RF-based device HabibTM 4X. All the other authors have no conflicts of interest, including specific financial interests or relationships and affiliations relevant to the subject matter or materials discussed in the manuscript.
Références
Science. 1999 Jul 30;285(5428):727-9
pubmed: 10426993
Int Immunol. 2000 Nov;12(11):1539-46
pubmed: 11058573
Nature. 2001 Mar 29;410(6828):604-8
pubmed: 11279501
Nat Immunol. 2002 Nov;3(11):991-8
pubmed: 12407406
Nat Immunol. 2002 Nov;3(11):999-1005
pubmed: 12407407
Cancer. 2003 Sep 1;98(5):1089-99
pubmed: 12942579
Cell. 1992 Dec 24;71(7):1093-102
pubmed: 1335364
Cancer Res. 2004 Feb 1;64(3):1140-5
pubmed: 14871849
In Vivo. 2004 Jan-Feb;18(1):81-100
pubmed: 15011756
Annu Rev Immunol. 2004;22:329-60
pubmed: 15032581
Semin Liver Dis. 2004 Feb;24(1):77-88
pubmed: 15085488
Nat Rev Immunol. 2005 Oct;5(10):749-59
pubmed: 16175180
Cancer Res. 2006 Jul 15;66(14):7285-92
pubmed: 16849578
Br J Cancer. 2006 Oct 9;95(7):896-905
pubmed: 16953240
Immunol Rev. 2006 Oct;213:131-45
pubmed: 16972901
J Exp Med. 1991 Sep 1;174(3):561-9
pubmed: 1714933
Clin Cancer Res. 2007 Feb 1;13(3):902-11
pubmed: 17289884
Blood. 2007 Aug 15;110(4):1225-32
pubmed: 17449799
Gastroenterology. 2007 Jun;132(7):2328-39
pubmed: 17570208
Gastroenterology. 2007 Jun;132(7):2557-76
pubmed: 17570226
J Natl Cancer Inst. 2008 May 21;100(10):698-711
pubmed: 18477802
Nat Rev Immunol. 2008 Jun;8(6):467-77
pubmed: 18500231
J Leukoc Biol. 2008 Oct;84(4):988-93
pubmed: 18515327
Oncologist. 2008;13 Suppl 4:2-9
pubmed: 19001145
Nat Rev Immunol. 2009 Mar;9(3):153-61
pubmed: 19240755
Hum Immunol. 2009 Jul;70(7):477-86
pubmed: 19332094
Ann Surg. 2009 May;249(5):799-805
pubmed: 19387322
Curr Pharm Des. 2009;15(16):1879-92
pubmed: 19519430
Scand J Immunol. 2009 Oct;70(4):326-36
pubmed: 19751267
Semin Cell Dev Biol. 2010 Feb;21(1):33-9
pubmed: 19896548
Hepatology. 2010 Apr;51(4):1284-90
pubmed: 20099299
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Gastroenterology. 2010 Sep;139(3):1030-40
pubmed: 20546740
Nat Rev Immunol. 2010 Jul;10(7):490-500
pubmed: 20559327
J Immunol. 2010 Aug 1;185(3):1544-9
pubmed: 20581151
BMC Gastroenterol. 2010 Jul 09;10:78
pubmed: 20618937
Ann Surg. 2011 Mar;253(3):453-69
pubmed: 21263310
Hepatology. 2011 Apr;53(4):1206-16
pubmed: 21480325
Immunol Rev. 2011 May;241(1):260-8
pubmed: 21488902
Eur J Immunol. 2011 Aug;41(8):2314-22
pubmed: 21674477
Cancer Res. 2011 Aug 15;71(16):5445-54
pubmed: 21708958
Mol Immunol. 2011 Oct;49(1-2):253-9
pubmed: 21937116
Cancer Res. 2012 Jan 15;72(2):430-9
pubmed: 22108823
J Hepatol. 2012 Mar;56(3):704-13
pubmed: 22120206
J Immunol. 2012 Feb 1;188(3):1117-24
pubmed: 22184722
Cancer Res. 2012 Feb 15;72(4):887-96
pubmed: 22205715
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
Dig Surg. 2012;29(1):43-7
pubmed: 22441619
Hepatology. 2013 Apr;57(4):1426-35
pubmed: 22576353
Clin Dev Immunol. 2012;2012:656340
pubmed: 22611421
J Hepatol. 2012 Oct;57(4):794-802
pubmed: 22634125
Oncoimmunology. 2012 Jan 1;1(1):48-55
pubmed: 22720211
Hepatology. 2013 Jan;57(1):205-16
pubmed: 22859060
Nat Rev Drug Discov. 2012 Oct;11(10):790-811
pubmed: 23000686
Nat Genet. 2012 Oct;44(10):1075-7
pubmed: 23011223
Hepatology. 2013 Apr;57(4):1448-57
pubmed: 23174905
Cancer Res. 2013 Apr 15;73(8):2435-44
pubmed: 23423978
Br J Cancer. 2013 Apr 30;108(8):1560-5
pubmed: 23511566
Immunobiology. 2013 Nov;218(11):1402-10
pubmed: 23891329
Hepatology. 2014 Feb;59(2):567-79
pubmed: 23960017
Hepatology. 2014 Apr;59(4):1415-26
pubmed: 24002931
J Clin Gastroenterol. 2014 May-Jun;48(5):450-7
pubmed: 24172183
Cancer Sci. 2014 Feb;105(2):150-8
pubmed: 24261990
Am J Pathol. 2014 Mar;184(3):574-83
pubmed: 24388934
Curr Opin Immunol. 2014 Apr;27:16-25
pubmed: 24531241
Nat Rev Cancer. 2014 Mar;14(3):199-208
pubmed: 24561446
World J Gastroenterol. 2014 Jun 28;20(24):7971-8
pubmed: 24976734
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Sci Rep. 2014 Nov 28;4:7252
pubmed: 25429732
Pharmacol Ther. 2015 Mar;147:22-31
pubmed: 25444759
Science. 2014 Dec 19;346(6216):1536-40
pubmed: 25525252
Nat Rev Immunol. 2015 Jan;15(1):45-56
pubmed: 25534622
Nat Genet. 2015 May;47(5):505-511
pubmed: 25822088
Biomed Res Int. 2015;2015:731469
pubmed: 25893197
Tumour Biol. 2015 Dec;36(12):9137-46
pubmed: 26423402
Cancer Immunol Res. 2015 Oct;3(10):1115-22
pubmed: 26438444
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):681-700
pubmed: 26484443
Am J Clin Oncol. 2016 Feb;39(1):98-106
pubmed: 26558876
Clin Cancer Res. 2016 Mar 1;22(5):1173-1184
pubmed: 26933175
Cancer. 2016 May 1;122(9):1312-37
pubmed: 26959385
Gastroenterol Res Pract. 2016;2016:9251375
pubmed: 27051417
Ann Transl Med. 2016 Mar;4(6):118
pubmed: 27127771
Immunotargets Ther. 2015 May 28;4:111-22
pubmed: 27471717
Immunity. 2016 Aug 16;45(2):389-401
pubmed: 27521269
Cancer Immunol Immunother. 2017 Feb;66(2):247-258
pubmed: 27585790
Sci Rep. 2016 Oct 11;6:35056
pubmed: 27725696
J Hepatol. 2017 Mar;66(3):545-551
pubmed: 27816492
Lancet Oncol. 2016 Dec;17(12):e542-e551
pubmed: 27924752
Oncotarget. 2017 Jan 17;8(3):4218-4227
pubmed: 27965468
Nature. 2017 Jan 18;541(7637):321-330
pubmed: 28102259
Oncotarget. 2017 Jun 13;8(24):39658-39672
pubmed: 28487498
Diagn Interv Imaging. 2017 Sep;98(9):651-659
pubmed: 28579522
Sci Rep. 2017 Sep 4;7(1):10376
pubmed: 28871164
JAMA Oncol. 2017 Dec 1;3(12):1683-1691
pubmed: 28983565
J Immunother Cancer. 2017 Oct 17;5(1):78
pubmed: 29037259
Oncotarget. 2017 Sep 26;8(55):93644-93654
pubmed: 29212179
Lancet. 2018 Mar 31;391(10127):1301-1314
pubmed: 29307467
Surg Oncol. 2018 Jun;27(2):A16-A18
pubmed: 29449067
Cell. 2018 Jul 26;174(3):549-563.e19
pubmed: 29937226
J Cancer. 2018 Aug 6;9(17):3187-3195
pubmed: 30210642
Surg Oncol. 2018 Sep;27(3):415-420
pubmed: 30217296
Clin Transl Oncol. 2018 Oct 27;:null
pubmed: 30368725
J Exp Med. 1995 Aug 1;182(2):459-65
pubmed: 7543139
J Immunol. 1995 Aug 1;155(3):1151-64
pubmed: 7636184